Pulmonx Corporation
LUNG
$1.35
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 88.55M | 90.50M | 91.66M | 90.55M | 87.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.55M | 90.50M | 91.66M | 90.55M | 87.47M |
| Cost of Revenue | 21.70M | 23.36M | 24.48M | 24.39M | 23.21M |
| Gross Profit | 66.84M | 67.14M | 67.19M | 66.16M | 64.27M |
| SG&A Expenses | 99.26M | 101.31M | 105.46M | 105.27M | 103.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 140.60M | 144.16M | 148.84M | 147.46M | 145.20M |
| Operating Income | -52.06M | -53.66M | -57.18M | -56.91M | -57.73M |
| Income Before Tax | -52.57M | -53.38M | -56.28M | -56.40M | -56.64M |
| Income Tax Expenses | 640.00K | 626.00K | 478.00K | 542.00K | 449.00K |
| Earnings from Continuing Operations | -53.21 | -54.00 | -56.75 | -56.94 | -57.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.21M | -54.00M | -56.75M | -56.94M | -57.09M |
| EBIT | -52.06M | -53.66M | -57.18M | -56.91M | -57.73M |
| EBITDA | -51.16M | -52.61M | -56.06M | -55.67M | -56.28M |
| EPS Basic | -1.29 | -1.33 | -1.41 | -1.43 | -1.45 |
| Normalized Basic EPS | -0.80 | -0.82 | -0.87 | -0.89 | -0.90 |
| EPS Diluted | -1.29 | -1.33 | -1.41 | -1.43 | -1.45 |
| Normalized Diluted EPS | -0.80 | -0.82 | -0.87 | -0.89 | -0.90 |
| Average Basic Shares Outstanding | 164.67M | 162.73M | 160.90M | 159.24M | 157.76M |
| Average Diluted Shares Outstanding | 164.67M | 162.73M | 160.90M | 159.24M | 157.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |